We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
-7.99%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$18.4B
AUM Growth
-$2.28B
Cap. Flow
-$623M
Cap. Flow %
-3.38%
Top 10 Hldgs %
32.43%
Holding
345
New
22
Increased
43
Reduced
37
Closed
30

Top Buys

Rank Stock Value
1
TWTR
Twitter, Inc.
TWTR
+$314M
2
DT icon
Dynatrace
DT
+$312M
3
CSGP icon
CoStar Group
CSGP
+$301M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$249M
5
CLVT icon
Clarivate
CLVT
+$237M

Top Sells

Rank Stock Value
1
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$411M
2
RTX icon
RTX Corp
RTX
+$335M
3
CERN
Cerner Corp
CERN
+$312M
4
AVGO icon
Broadcom
AVGO
+$257M
5
PLAN
Anaplan, Inc.
PLAN
+$102M

Sector Composition

Rank Sector Weight
1 Healthcare 30.97%
2 Technology 17.59%
3 Financials 14.68%
4 Industrials 9.18%
5 Communication Services 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMPX icon
301
Compass Therapeutics
CMPX
$432M
– –
-582,750
Closed -$798K
DRIO icon
302
DarioHealth
DRIO
$73.4M
– –
-6,654
Closed -$777K
EXAS
303
DELISTED
Exact Sciences
EXAS
– –
-802,898
Closed -$56.1M
FATE icon
304
Fate Therapeutics
FATE
$279M
– –
-31,900
Closed -$1.24M
KYNB
305
Kyntra Bio
KYNB
$30.4M
– –
-14,591
Closed -$4.38M
GROV icon
306
Grove Collaborative
GROV
$41.9M
– –
-200,000
Closed -$9.86M
PACB icon
307
Pacific Biosciences
PACB
$420M
– –
-1,631,800
Closed -$14.8M
RGEN icon
308
Repligen
RGEN
$10.2B
– –
-222,979
Closed -$41.9M
RTX icon
309
RTX Corp
RTX
$283B
– –
-3,385,484
Closed -$335M
VCYT icon
310
Veracyte
VCYT
$3.4B
– –
-32,500
Closed -$896K
PNT
311
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
– –
-626,322
Closed -$4.99M
SPCMU
312
DELISTED
Sound Point Acquisition Corp I, Ltd Unit
SPCMU
– –
-300,000
Closed -$3.02M
GBT
313
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-169,458
Closed -$5.87M
ZEAL
314
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
– –
-496,890
Closed -$7.75M
PLAN
315
DELISTED
Anaplan, Inc.
PLAN
– –
-1,570,000
Closed -$102M
VGII.WS
316
DELISTED
Virgin Group Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one Class
VGII.WS
– –
-200,000
Closed -$76K
DIDI
317
DELISTED
DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share
DIDI
– –
-16,868,328
Closed -$42.2M
CERN
318
DELISTED
Cerner Corp
CERN
– –
-3,339,955
Closed -$312M
CAS.WS
319
DELISTED
Cascade Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Class
CAS.WS
– –
-495,000
Closed -$87K
CAS
320
DELISTED
Cascade Acquisition Corp.
CAS
– –
-990,000
Closed -$9.98M
OCDX
321
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
– –
-2,426,913
Closed -$45.3M
ZNGA
322
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
– –
-44,475,000
Closed -$411M
ZNGA
323
PUT
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
– –
-1,500,000
Closed -$13.9M
FOE
324
DELISTED
Ferro Corporation
FOE
– –
-114,963
Closed -$2.5M
PBCT
325
DELISTED
People's United Financial Inc
PBCT
– –
-485,000
Closed -$9.7M
10 11 12
13
14

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q2 2022 Portfolio in Review

As of Q2 2022, Thomas Steyer held 345 positions worth $18.4B, down 11% from $20.7B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Thomas Steyer withdrew a net $623M in Q2 2022, closing 30 positions and reducing 37 holdings. Its most notable exit was ZYNGA INC. CL A COMMON, an estimated $411M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

Against the trend, Thomas Steyer opened a new position in Twitter, Inc. worth $274M.

  • Thomas Steyer's largest Q2 2022 buy was Twitter, Inc.: 7,325,000 shares worth $274M.
  • Thomas Steyer added most to Clarivate in Q2 2022, an estimated $237M increase.
  • Thomas Steyer's biggest Q2 2022 reduction was AbbVie, cutting an estimated $97.7M.
  • Thomas Steyer fully exited ZYNGA INC. CL A COMMON in Q2 2022, selling an estimated $411M.
  • Thomas Steyer's ten largest holdings make up 32% of its $18.4B portfolio in Q2 2022.
  • Thomas Steyer opened 22 new positions and closed 30 in Q2 2022.
  • Thomas Steyer's portfolio value fell 11% quarter-over-quarter to $18.4B.

Based on Farallon Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.